233 related articles for article (PubMed ID: 16966094)
1. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
Emond C; Birnbaum LS; DeVito MJ
Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.
Evans MV; Andersen ME
Toxicol Sci; 2000 Mar; 54(1):71-80. PubMed ID: 10746933
[TBL] [Abstract][Full Text] [Related]
3. The effect of dose on 2,3,7,8-TCDD tissue distribution, metabolism and elimination in CYP1A2 (-/-) knockout and C57BL/6N parental strains of mice.
Hakk H; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 2009 Nov; 241(1):119-26. PubMed ID: 19695277
[TBL] [Abstract][Full Text] [Related]
4. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
6. A pharmacodynamically responsive model of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) transfer between liver and fat at low and high doses.
Roth WL; Ernst S; Weber LW; Kerecsen L; Rozman KK
Toxicol Appl Pharmacol; 1994 Jul; 127(1):151-62. PubMed ID: 8048047
[TBL] [Abstract][Full Text] [Related]
7. Physiological modeling of a proposed mechanism of enzyme induction by TCDD.
Kohn MC; Walker NJ; Kim AH; Portier CJ
Toxicology; 2001 May; 162(3):193-208. PubMed ID: 11369115
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
[TBL] [Abstract][Full Text] [Related]
9. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat.
Emond C; Birnbaum LS; DeVito MJ
Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
Abraham K; Krowke R; Neubert D
Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
[TBL] [Abstract][Full Text] [Related]
15. Subchronic Exposure of [3H]- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: relationship of steady-state levels to disposition and metabolism.
Diliberto JJ; DeVito MJ; Ross DG; Birnbaum LS
Toxicol Sci; 2001 Jun; 61(2):241-55. PubMed ID: 11353133
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling.
Emond C; DeVito MJ; Diliberto JJ; Birnbaum LS
Toxicol Sci; 2018 Jul; 164(1):218-228. PubMed ID: 29596651
[TBL] [Abstract][Full Text] [Related]
17. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
Andersen ME; Birnbaum LS; Barton HA; Eklund CR
Toxicol Appl Pharmacol; 1997 May; 144(1):145-55. PubMed ID: 9169078
[TBL] [Abstract][Full Text] [Related]
18. Toxic potency of 3,3',4,4',5-pentachlorobiphenyl relative to and in combination with 2,3,7,8-tetrachlorodibenzo-p-dioxin in a subchronic feeding study in the rat.
Van Birgelen AP; Van der Kolk J; Fase KM; Bol I; Poiger H; Brouwer A; Van den Berg M
Toxicol Appl Pharmacol; 1994 Aug; 127(2):209-21. PubMed ID: 8048064
[TBL] [Abstract][Full Text] [Related]
19. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
20. Effects of CYP1A2 on disposition of 2,3,7, 8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 2,2',4,4',5,5'-hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice.
Diliberto JJ; Burgin DE; Birnbaum LS
Toxicol Appl Pharmacol; 1999 Aug; 159(1):52-64. PubMed ID: 10448125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
